The Cochrane Library: Cochrane Database of Systematic Reviews

DOI: 10.1002/14651858

Reviews/Protocols listed by Cochrane Review Group


  1. Cochrane Acute Respiratory Infections Group
  2. Cochrane Airways Group
  3. Cochrane Anaesthesia Group
  4. Cochrane Back Group
  5. Cochrane Bone, Joint and Muscle Trauma Group
  6. Cochrane Breast Cancer Group
  7. Cochrane Childhood Cancer Group
  8. Cochrane Colorectal Cancer Group
  9. Cochrane Consumers and Communication Group
  10. Cochrane Cystic Fibrosis and Genetic Disorders Group
  11. Cochrane Dementia and Cognitive Improvement Group
  12. Cochrane Depression, Anxiety and Neurosis Group
  13. Cochrane Developmental, Psychosocial and Learning Problems Group
  14. Cochrane Drugs and Alcohol Group
  15. Cochrane Ear, Nose and Throat Disorders Group
  16. Cochrane Effective Practice and Organisation of Care Group
  17. Cochrane Epilepsy Group
  18. Cochrane Eyes and Vision Group
  19. Cochrane Fertility Regulation Group
  20. Cochrane Gynaecological Cancer Group
  21. Cochrane Haematological Malignancies Group
  22. Cochrane Heart Group
  23. Cochrane Hepato-Biliary Group
  24. Cochrane HIV/AIDS Group
  25. Cochrane Hypertension Group
  26. Cochrane Incontinence Group
  27. Cochrane Infectious Diseases Group
  28. Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Group
  29. Cochrane Injuries Group
  30. Cochrane Lung Cancer Group
  31. Cochrane Menstrual Disorders and Subfertility Group
  32. Cochrane Metabolic and Endocrine Disorders Group
  33. Cochrane Methodology Review Group
  34. Cochrane Movement Disorders Group
  35. Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group
  36. Cochrane Musculoskeletal Group
  37. Cochrane Neonatal Group
  38. Cochrane Neuromuscular Disease Group
  39. Cochrane Occupational Safety and Health Group
  40. Cochrane Oral Health Group
  41. Cochrane Pain, Palliative and Supportive Care Group
  42. Cochrane Peripheral Vascular Diseases Group
  43. Cochrane Pregnancy and Childbirth Group
  44. Cochrane Prostatic Diseases and Urologic Cancers Group
  45. Cochrane Public Health Group
  46. Cochrane Renal Group
  47. Cochrane Schizophrenia Group
  48. Cochrane Sexually Transmitted Infections Group
  49. Cochrane Skin Group
  50. Cochrane Stroke Group
  51. Cochrane Tobacco Addiction Group
  52. Cochrane Upper Gastrointestinal and Pancreatic Diseases Group
    1. About this group
    2. Reviews
      1. Abdominal drainage versus no drainage post gastrectomy for gastric cancerReview
      2. Additional bedtime H2-receptor antagonist for the control of nocturnal gastric acid breakthroughReview
      3. Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitisReview
      4. Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescentsReview
      5. Antioxidants for pain in chronic pancreatitisReview
      6. Argon plasma coagulation therapy for acute non-variceal upper gastrointestinal bleedingReview
      7. Botulinum toxin for upper oesophageal sphincter dysfunction in neurological swallowing disordersReview
      8. Chemotherapy and radiotherapy for inoperable advanced pancreatic cancerReview
      9. Chemotherapy for advanced gastric cancerReview
      10. Chemotherapy for metastatic carcinoma of the esophagus and gastro-esophageal junctionReview
      11. Chinese herbal medicines for acute pancreatitisReview
      12. Chinese herbal medicines for esophageal cancerReview
      13. Chinese herbal medicines for induction of remission in advanced or late gastric cancerReview
      14. Cisapride treatment for gastro-oesophageal reflux in childrenReview
      15. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagusReviewWithdrawn
      16. Comparison of different regimens of proton pump inhibitors for acute peptic ulcer bleedingReview
      17. Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancerReviewDiagnostic
      18. Early routine endoscopic retrograde cholangiopancreatography strategy versus early conservative management strategy in acute gallstone pancreatitisReview
      19. Early versus delayed laparoscopic cholecystectomy for acute gallstone pancreatitisReview
      20. Endoscopic mucosal resection for early gastric cancerReview
      21. Endoscopic or surgical intervention for painful obstructive chronic pancreatitisReview
      22. Endoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasiaReview
      23. Endoscopic retrograde cholangiopancreatography in gallstone-associated acute pancreatitisReviewWithdrawn
      24. Enteral versus parenteral nutrition for acute pancreatitisReview
      25. Epinephrine injection versus epinephrine injection and a second endoscopic method in high risk bleeding ulcersReview
      26. Eradication of Helicobacter pylori for non-ulcer dyspepsiaReviewWithdrawn
      27. Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patientsReview
      28. Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomachReview
      29. Guidewire-assisted cannulation of the common bile duct for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitisReview
      30. Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcerReview
      31. Initial management strategies for dyspepsiaReview
      32. Interventions for dysphagia in oesophageal cancerReviewWithdrawn
      33. Laparoscopic repair for perforated peptic ulcer diseaseReview
      34. Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux diseaseReviewWithdrawn
      35. Medical treatments in the short term management of reflux oesophagitisReviewWithdrawn
      36. Medical versus surgical management for gastro-oesophageal reflux disease (GORD) in adultsReview
      37. Metoclopramide for migration of naso-enteral tubeReview
      38. Metoclopramide, thickened feedings, and positioning for gastro-oesophageal reflux in children under two yearsReview
      39. Neoadjuvant chemotherapy versus none for resectable gastric cancerReviewWithdrawn
      40. Nitrates for achalasiaReview
      41. Non-surgical interventions for eosinophilic esophagitisReview
      42. Omentoplasty for esophagogastrostomy after esophagectomyReview
      43. Opioids for acute pancreatitis painReview
      44. Optimum duration of regimens for Helicobacter pylori eradicationReview
      45. Palliative biliary stents for obstructing pancreatic carcinomaReview
      46. Pancreatic enzymes for chronic pancreatitisReview
      47. Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbancesReview
      48. Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagusReview
      49. Pharmacological interventions for non-ulcer dyspepsiaReviewWithdrawn
      50. Post-surgical chemotherapy versus surgery alone for resectable gastric cancerReview
      51. Preoperative chemotherapy for resectable thoracic esophageal cancerReview
      52. Preoperative radiotherapy for esophageal carcinomaReview
      53. Prevention of NSAID-induced gastroduodenal ulcersReview
      54. Prophylactic gastrojejunostomy for unresectable periampullary carcinomaReview
      55. Proton pump inhibitor treatment for acute peptic ulcer bleedingReview
      56. Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleedingReview
      57. Psychological interventions for non-ulcer dyspepsiaReviewWithdrawn
      58. Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinomaReview
      59. Red cell transfusion for the management of upper gastrointestinal haemorrhageReview
      60. Resection versus other treatments for locally advanced pancreatic cancerReview
      61. Screening for oesophageal cancerReview
      62. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux diseaseReview
      63. Somatostatin analogues for pancreatic surgeryReview
      64. Stents for the prevention of pancreatic fistula following pancreaticoduodenectomyReview
      65. Surgery versus radical endotherapies for early cancer and high-grade dysplasia in Barrett's oesophagusReview
      66. Surveillance of gastric intestinal metaplasia for the prevention of gastric cancerReview
      67. Tranexamic acid for upper gastrointestinal bleedingReview
      68. Treatment for Barrett's oesophagusReview
    3. Protocols
      1. Acupuncture for functional dyspepsiaProtocol
      2. Antacids and lifestyle advice for reflux oesophagitis and Endoscopy Negative Reflux DiseaseProtocol
      3. Antidepressants and anxiolytics for functional dyspepsiaProtocol
      4. Antioxidants for acute pancreatitisProtocol
      5. Antiproteases for acute pancreatitisProtocol
      6. Biodegradable anastomotic ring for gastrointestinal anastomosisProtocol
      7. Carbon dioxide detection for diagnosis of inadvertent respiratory tract placement of enterogastric tubes in childrenProtocolDiagnostic
      8. Carbon dioxide detection for testing nasogastric tube placement in adultsProtocolDiagnostic
      9. Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancerProtocol
      10. Chemotherapy, radiotherapy, chemoradiotherapy and combination therapy in localised and locally advanced pancreatic cancerProtocol
      11. Chinese herbal medicine alone or combined with vitamins for gastric precancerous lesionsProtocol
      12. Chinese herbal medicine for advanced pancreatic cancerProtocol
      13. Conservative interventions for the management of impacted food bolus in the oesophagusProtocol
      14. Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancerProtocolDiagnostic
      15. Electrosurgical current for endoscopic biliary sphincterotomy (EBS) for the prevention of post endoscopic retrograde cholangiopancreatography (ERCP) pancreatitisProtocol
      16. Endoscopic drainage with or without endo-ultrasonography for pancreatic pseudocystProtocol
      17. Endoscopic intervention for the prevention of post endoscopic retrograde cholangiopancreatography (ERCP) pancreatitisProtocolWithdrawn
      18. Enteral nutrition formulations for acute pancreatitisProtocol
      19. Fasting for haemostasis in children with gastrointestinal bleedingProtocol
      20. Fibrin sealants for the prevention of postoperative pancreatic fistula following pancreatic surgeryProtocol
      21. Helicobacter pylori eradication for premalignant lesions of the gastric mucosaProtocol
      22. Helicobacter pylori eradication for the prevention of gastric neoplasiaProtocol
      23. High dose versus standard dose proton pump inhibitor for short term management of erosive reflux oesophagitisProtocol
      24. Imaging modalities for characterising focal pancreatic lesionsProtocolDiagnostic
      25. Imatinib mesylate for gastrointestinal stromal tumours (GISTs)ProtocolWithdrawn
      26. Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care unitsProtocol
      27. Intraperitoneal chemotherapy for gastric carcinomaProtocol
      28. Laparoscopic cardiomyotomy versus endoscopic pneumatic dilation for primary achalasiaProtocol
      29. Laparoscopic fundoplication for gastro-oesophageal reflux disease (GORD) in adultsProtocol
      30. Lexipafant for acute pancreatitisProtocol
      31. Long term proton pump inhibitor (PPI) use and incidence of gastric premalignant lesionsProtocol
      32. Mesh reinforcement versus primary repair in laparoscopic paraoesophageal hernia repairs of the hiatusProtocol
      33. Minimal access drainage procedures for patients with necrotising pancreatitisProtocol
      34. Nasogastric versus nasojejunal tube feeding for severe acute pancreatitisProtocol
      35. Nonsteroidal anti-inflammatories (NSAIDs) and aspirin for intestinal metaplasia of the stomachProtocol
      36. Optimum antibiotic doses for Helicobacter pylori eradicationProtocol
      37. Pancreatic duct guidewire placement for biliary cannulation for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP)Protocol
      38. Percutaneous endoscopic gastrostomy versus radiologically placed gastrostomies for swallowing disturbancesProtocol
      39. Periodontal therapy as adjunctive treatment for gastric Helicobacter pylori infectionProtocol
      40. Pharmacologic and radiotherapeutic interventions for advanced pancreatic cancerProtocol
      41. Pharmacological treatment for gastro-oesophageal reflux in childrenProtocol
      42. Postoperative chemotherapy or radiotherapy for esophageal cancerProtocol
      43. Preoperative radiotherapy chemotherapy and surgery versus surgery alone for esophageal cancerProtocol
      44. Probiotics as adjunctive therapy for eradication of Helicobacter pylori infectionProtocol
      45. Prokinetics for functional dyspepsiaProtocol
      46. Prophylactic abdominal drainage for pancreatic surgeryProtocol
      47. Proton pump inhibitor-based triple therapies versus dual therapies for Helicobacter pylori eradicationProtocol
      48. Proton pump inhibitor versus placebo in the short term management of gastro-esophageal reflux diseaseProtocol
      49. Proton pump inhibitors for functional dyspepsiaProtocol
      50. Routine cholecystectomy during Roux-en-Y gastric bypass with or without choledocholithiasisProtocol
      51. Sequential versus standard triple therapy for Helicobacter pylori eradicationProtocol
      52. Somatostatin analogues for carcinoid syndromeProtocol
      53. Somatostatin or somatostatin analogues for acute non-variceal upper gastrointestinal bleedingProtocol
      54. Stapler versus scalpel resection followed by hand-sewn closure of the pancreatic remnant for distal pancreatectomyProtocol
  53. Cochrane Wounds Group

SEARCH